K Pharma, Inc.

4896・Growth Market・Pharmaceuticals

Official website

K Pharma, Inc.

4896・Growth Market・Pharmaceuticals

Official website

K Pharma, Inc.4896

Reference Indicators

Market Cap

84¥100M

P/E (Forecast)

—

P/B

6.7x

Dividend Yield (Forecast)

0.00%

ROE

-78.5%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	1,000	—	—
Cost of Sales	90	—	—
Gross Profit	910	—	—
SG&A Expenses	543	836	916
Operating Income	366	-836	-916
Non-operating Income	0	1	3
Non-operating Expenses	21	1	7
Ordinary Income	344	-836	-920
Extraordinary Losses	43	7	69
Pre-tax Income	301	-844	-990
Income Taxes	40	2	2
Net Income	260	-846	-993
Gross Margin	91.0%	—	—
Operating Margin	36.6%	—	—
ROA	7.9%	-36.0%	-33.8%
ROE	11.7%	-37.5%	-78.5%